We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PFGRUPSURA:BVCGrupo de Inversiones Suramericana SA Pfd Analysis

Data as of 2026-03-17 - not real-time

COP 40,380.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

PFGRUPSURA is trading at 40,380 COP, comfortably below its 20‑day (46,507 COP), 50‑day (48,132 COP) and 200‑day (41,443 COP) simple moving averages, signaling bearish price pressure. However, the 14‑day RSI sits at 32, indicating an oversold condition, while the MACD histogram remains negative and volume is trending down, suggesting limited buying momentum in the short run. Volatility is high at 54 % over the past 30 days, yet the beta is low (~0.14), meaning price swings are largely driven by company‑specific factors rather than broad market moves.
Fundamentally, the stock appears attractively priced: a trailing P/E of 9.6 versus the industry average of 16.5, a P/B of 0.68, and a 5 % dividend yield supported by a modest 26 % payout ratio. Cash on hand (15.3 T COP) exceeds total debt (11.9 T COP), and revenue growth is robust at 88 % year‑over‑year, with free cash flow of 19.7 T COP. The company’s diversified presence across 12 countries adds medium regulatory and geographic risk, and current trading volume is below its 10‑day and 3‑month averages, indicating a liquidity constraint.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price is near the identified support level of 38,700 COP
  • RSI of 32 suggests the stock may be oversold
  • Bearish MACD and decreasing volume warrant caution

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Valuation multiples are attractive (P/E 9.6 vs 16.5 industry)
  • Strong cash position net of debt provides financial flexibility
  • High dividend yield of 5% with a sustainable payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained revenue growth of 88% year‑over‑year
  • Diversified insurance and asset‑management footprint across Latin America
  • Low beta reduces exposure to broad market volatility

Key Metrics & Analysis

Financial Health

Revenue Growth88.40%
Profit Margin6.46%
P/E Ratio9.6
ROE8.96%
ROA2.90%
Debt/Equity55.53
P/B Ratio0.7
Op. Cash FlowCOP4065.1B
Free Cash FlowCOP19656.4B
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI32.1
SupportCOP 38,700.00
ResistanceCOP 53,000.00
MA 20COP 46,507.00
MA 50COP 48,131.60
MA 200COP 41,441.98
MACDBearish
VolumeDecreasing
Fear & Greed Index79.45

Valuation

Fair ValueCOP 2,242,811.19
GradeUndervalued
TypeBlend
Dividend Yield5.00%

Risk Assessment

Beta0.14
Volatility54.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.